A new biotechnology companies, pharmaceutical Technologies has developed a competing process for the treatment of erectile dysfunction, the significant advantages over Pfizer’s blockbuster drug, Viagra promises. With deep-pocketed pharmaceutical company is also pursuing product development, the president of the Pharmaceutical Technologies, is charged with deciding how the use of his company closes superior proprietary technology into a marketable product in front of the window of opportunity.

A new biotechnology companies, pharmaceutical Technologies has developed a competing process for the treatment of erectile dysfunction, the significant advantages over Pfizer’s blockbuster drug, Viagra promises. With deep-pocketed pharmaceutical company is also pursuing product development, the president of the Pharmaceutical Technologies, is charged with deciding how the use of his company closes superior proprietary technology into a marketable product in front of the window of opportunity.
«Hide

from
Charlene L. Nicholls-Nixon,
Roderick E. White,
John Herbert
Source: Ivey Publishing
14 pages.
Publication Date: Sep 21, 2004. Prod #: 904M64-PDF-ENG
Pharma Technologies Inc. HBR case solution

[related_post themes="flat"]